Connect your AI

CRISPR Therapeutics CRSP Earnings yield

Earnings yield at other companies

CG OncologyCGON

-3.3%-1.0pp

Cogent Biosciences, Inc.COGT

-5.7%-2.6pp

Arrowhead ResearchARWR

-3.4%-1.3pp

BridgeBio PharmaBBIO

-5.1%-1.7pp

Krystal Biotech, Inc.KRYS

3%+0.6pp

Spyre Therapeutics, Inc.SYRE

-4.5%-2.0pp

Other financials

Income statement

Revenue$1.5M+68.6%

Operating income-$130.2M+12.2%

Net income-$122.9M+9.6%

EPS (diluted)-$1.28+19.0%

Balance sheet

Cash & equivalents$423.3M+80.0%

Total debt$787.6M+259%

Total equity$1.8B-0.8%

Total assets$2.7B+25.8%

Cash flow

Operating cash flow-$108.9M-102%

CapEx$504.0K+145%

Free cash flow-$109.4M-102%

Valuation

Market cap$5.33B+56.4%

Enterprise value$5.69B+69.8%

P/S1,298.3×+1,208×

Profitability

Operating margin-15,754.2%-17,253pp

Net margin-13,856.5%-15,058pp

FCF margin-9,777.6%-10,759pp

Returns & leverage

Return on equity-31.2%+43.7pp

Debt / equity0.4×+0.3×

Current ratio18×+2.3×

Where this comes from

Calculated from CRISPR Therapeutics’s reported figures.

net income/market cap=-12.5%

Based on trailing twelve months.

The official record: CRISPR Therapeutics’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about CRISPR Therapeutics's earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is CRISPR Therapeutics's earnings yield?: CRISPR Therapeutics (CRSP) reported earnings yield of -12.5% in Q1 2026.
How has CRISPR Therapeutics's earnings yield changed year-over-year?: CRISPR Therapeutics's earnings yield increased by 5.8% year-over-year, from -13.2% to -12.5%.
What is the long-term trend for CRISPR Therapeutics's earnings yield?: Over 3 years (2020 to 2025), CRISPR Therapeutics's earnings yield has grown at a 57.5% compound annual growth rate (CAGR), from -3% to -11.6%.
What does earnings yield mean?: Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.